Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Numeta G16%E emulsion for infusion
Medicines register · Ireland

Numeta G16%E emulsion for infusion

Authorisation PA2299/030/001 · Baxter Holding B.V.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 19 Nov 2026
Licence holder
Baxter Holding B.V. (all products →)
Active substances
Alanine, Arginine, Aspartic Acid, Cysteine, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine monohydrate, Methionine, Ornithine hydrochloride, Phenylalanine, Proline, Serine, Taurine, Threonine, Tryptophan, Tyrosine, Valine, Sodium chloride, Potassium acetate, Calcium chloride dihydrate, Magnesium acetate tetrahydrate, Sodium glycerophosphate, hydrated, Glucose monohydrate, Refined olive oil + refined soybean oil
Clinical trials
2 clinical trials → 3 clinical trials → 3 clinical trials → 3 clinical trials →
Dosage form
Emulsion for infusion
Route of administration
Intravenous use
ATC codes
B05BA, B05BA10
First authorised
05/12/2011
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Fixed combination application (Article 10b of Directive No 2001/83/EC)

Alanine: supply and approvals

19 authorised products on the HPRA list contain Alanine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 18 Nov 2026)
Germany (BfArM)
6 supply notices, e.g. Aminosteril N-Hepa 8% (22 Apr 2026 to 31 Dec 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Arginine: supply and approvals

18 authorised products on the HPRA list contain Arginine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 18 Nov 2026)
Germany (BfArM)
6 supply notices, e.g. Aminosteril N-Hepa 8% (22 Apr 2026 to 31 Dec 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Aspartic Acid: supply and approvals

15 authorised products on the HPRA list contain Aspartic Acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 18 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 18 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 14 years (since 5 December 2011). The HPRA list marks it as marketed in Ireland.

Other medicines with Alanine in Ireland

32 other products on the HPRA list contain Alanine, from 4 licence holders; 20 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Finomel Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Finomel Peri Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Kabiven Peripheral emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
Kabiven emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
Numeta G13%E Preterm emulsion for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Numeta G19%E emulsion for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Omeflex peri emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex plus emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex special emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex special without electrolytes emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
SmofKabiven Peripheral, emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
SmofKabiven extra Nitrogen, emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed

All 33 products with Alanine →

Other medicines with Arginine in Ireland

28 other products on the HPRA list contain Arginine, from 4 licence holders; 20 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Finomel Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Finomel Peri Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Kabiven Peripheral emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
Kabiven emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
Numeta G13%E Preterm emulsion for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Numeta G19%E emulsion for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Omeflex peri emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex plus emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex special emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
Omeflex special without electrolytes emulsion for infusionB. Braun Melsungen AGNational authorisation (PA)Marketed
SmofKabiven Peripheral, emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed
SmofKabiven extra Nitrogen, emulsion for infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed

All 29 products with Arginine →

Other substances in ATC group B05BA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 65 other active substances share the group B05BA with this product:

Sodium acetate trihydrate (14) · Potassium chloride (13) · Lysine acetate (11) · Lysine hydrochloride (10) · Fish oil, rich in omega-3 acids (10) · Glucose anhydrous (10) · Soya bean oil, refined (9) · Triglycerides, medium chain (9) · Olive oil, refined (8) · Glucose (8) · Magnesium chloride hexahydrate (6) · Sodium hydroxide (6) · Histidine hydrochloride monohydrate (6) · Lysine (6) · L-leucine (4) · L-phenylalanine (4) · L-methionine (4) · L-isoleucine (4) · L-valine (4) · L-histidine (4) · and 45 more

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Baxter Holding B.V. holds 73 products on the HPRA list, with 111 different active substances; 62 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.